Loading…
CT Vapors, an e-liquid manufacturer, was found to be manufacturing and distributing tobacco products without required premarket authorization as mandated by the Family Smoking Prevention and Tobacco Control Act. The company's e-liquid products met the FDA's definition of tobacco products subject to regulation under the Federal Food, Drug, and Cosmetic Act, yet lacked the necessary marketing authorization orders for new tobacco products required since the FDA's deeming rule took effect on August 8, 2016. The Center for Tobacco Products determined the company was in violation of sections 201(rr), 901(b), and 910(a) of the FD&C Act and applicable regulations at 21 C.F.R. § 1100.1.